One Health Analytics  ·  Zoonotic Disease Surveillance

The One Health Signal

Weekly and monthly surveillance of the animal–human interface

The One Health Signal reports zoonotic and emerging infectious disease signals detected across open scientific, governmental and news sources, with particular attention to the animal–human interface that human-health surveillance tends to observe late.

Published without interruption since 16 June 2026. There is no charge, and you may unsubscribe at any time.

Letter of intent

Letter of Intent to Subscribe
One Health Analytics LLC  ·  The One Health Signal
Reference

Preamble

The One Health Signal is a periodical of zoonotic and emerging infectious disease surveillance published by One Health Analytics LLC, a limited liability company organised under the laws of the State of Delaware, United States. It is compiled from open scientific, governmental and news sources, with particular attention to the animal–human interface, and has been issued without interruption since 16 June 2026 in daily, weekly and monthly editions.

The undersigned, having reviewed the publication, states as follows.

  1. Intent to subscribeThe undersigned intends to subscribe to The One Health Signal and requests that it be delivered to the electronic mail address given below.
  2. Scope of deliveryThe undersigned consents to receive the weekly and monthly editions by electronic mail. The reports are provided without charge and no payment is or will be required.
  3. Use of informationThe particulars given below are used solely to deliver the reports and to record this letter. They are not sold, shared or transferred to any third party.
  4. WithdrawalThis consent may be withdrawn at any time and without condition, by reply to any issue or by notice to reports@onehealth-analytics.org.
  5. EffectThis letter takes effect on the date of signature recorded below and remains in effect until withdrawn by the undersigned.
Sign above using your mouse, trackpad or finger

Your details are used only to deliver the reports and to record this letter of intent. They are not sold or shared. To withdraw, reply to any issue or write to the address below.